Порошок наттокиназе 5000 фу уф

Что такое Порошок наттокиназы 5000FU?

Nattokinase-щелочная сериновая протеаза, получаемая в процессе метаболизма Bacillus subtilis, одноцепная полипептидная структура без дисульфидных связей, растворимая в воде, желтоватая или белая в твердом состоянии. Последовательность дезоксирибонуклеиновой кислоты (ДНК) наттокиназы состоит из 275 остатков аминокислоты, а ее относительная молекулярная масса, как правило, составляет 28000 у.

Порошок Nattokinase является естественным ферментом, также известный как Bacillus subtilis фибринолитный фермент, QK фибринолитный фермент Nattokinase имеет фибринолитный фермент, как свойства, которые разрушают фибрин. Nattokinase также стимулирует тело и#39; естественное производство фибринолитных ферментов для поддержания нормальной кровообращения, потока и вязкости крови. Наттокиназа особенно чувствительна к взаимосвязанному фибрину (фибрин, который сформировал тромб крови) и может разлагаться непосредственно, без воздействия на фибрин плазмы и без риска кровотечения. У наттокиназы разный тромболитический механизм. В дополнение к прямому тромболитическому эффекту, описанному выше, существует небольшой косвенный тромболитический эффект.

Технология Green Spring обеспечивает порошок Nattokinase 5000 фу уф без витамина K2 и без особого запаха аммиака. Мы используем высококачественную ферментацию чистого штамма Nattokinase, короткий производственный цикл, высокую урожайность, низкую цену и простоту извлечения и очистки. С командой передовых научных исследований, опытной командой управления производством и командой профессиональных продаж, Green Spring может настроить различные соотношения экстрактов, а также стандартных экстрактов по мере необходимости. Мы прошли халальную, кошерную, космическую, BRC, IFS, FDA, ISO и другие сертификации. Мы можем предоставить авторитетные отчеты третьих сторон об испытаниях.

Технические характеристики: 

Правила и положения:

Он соответствует правилам ес.

Benefits:

Reduces Blood Clot Formation

Clotting is formed through a series of chemical reactions between special blood cells (platelets) and proteins (clotting factors) in the blood and is an important defense mechanism for the body. Sometimes this process is abnormal and an abnormal clot (also known as a thrombus) develops in an artery or vein, blocking the flow of blood to surrounding tissues. Among these, acute arterial thrombosis is the proximal cause of most myocardial infarctions (heart attacks) and about 80% of strokes. In an open-label clinical trial (45 adults) with 3 groups, healthy, cardiovascular, and dialysis, all subjects were given 2 nattokinase capsules (nattokinase, a single dose of 2,000 FU) orally daily for 2 months.

The results found that coagulation factors associated with cardiovascular disease, such as fibrinogen, coagulation factor VII, and coagulation factor VIII, decreased consistently and at similar rates in all groups. Another double-blind, placebo-controlled trial (in 12 healthy young men) noted that D-dimer concentrations and blood fibrin/fibrinogen degradation products were elevated in subjects taking oral nattokinase and that the duration of action was longer (~8 hours or more).

Conclusion: Oral nattokinase may have a positive effect on inhibiting thrombosis, but more large trials are needed to confirm its clinical benefit, limited by the small sample size.

Prevention of Atherosclerosis

Atherosclerosis is a chronic disease in which arteries harden through plaque formation. Major risk factors include dyslipidaemia, diabetes, smoking, hypertension and genetic abnormalities. A randomised controlled trial (26 weeks in 82 patients with hyperlipidaemia) was conducted with two groups, one given a lipid-lowering drug: simvastatin, and the other given nattokinase (6000 FU daily dose).

After the test, it was found that the common carotid artery intima-media thickness (CCA-IMT) and carotid plaque size decreased in both groups, but the magnitude was more significant in the nattokinase group. In addition, lipid indices such as TG, TC and LDL-C decreased in both groups, but the magnitude was more significant in the simvastatin group, while nattokinase powder was able to increase HDL-C.

Conclusion: Oral nattokinase may be useful in the prevention of atherosclerosis, but due to the small sample size, more large-scale trials are needed to confirm the clinical benefits.

Liver Protection

After Nattokinase powder enters the human body, it builds an alcohol protection barrier through a triple channel: it enters the human liver system to break down the pressure on the liver to resolve alcohol and assist in alcohol detoxification; it enters the human vascular system to form a key protection barrier in the cerebrovascular region to resist the inhibitory effect of alcohol on the brain; and it enters the human digestive tract system to form a protective barrier rapidly to accelerate the acidic secretion of the digestive tract and promote alcohol detoxification.

Taking Natto can quickly solve the adverse effects of alcohol and prevent next-day drunkenness. In addition, a variety of active substances in natto activate liver cells, promote liver cell regeneration, improve liver function, protect the liver, and effectively prevent and improve fatty liver.

Applications:

For Health Products:

Nattokinase powder is widely used as a food supplement for blood thinning, prevention of thrombosis, and improvement of blood circulation in Japan, China, Korea, EU countries, Canada, and the United States. Nattokinase also has a variety of pharmacological effects such as improving microcirculation, lowering blood pressure, anticoagulation, preventing atherosclerosis, easing retinal angiogenesis, anticancer, and inhibiting inflammation and oxidative stress. It has been used as a nutraceutical additive.